The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BDPT · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | PCRX | BDPT | INGN | SGRY |
|---|---|---|---|---|
| Moat Score (0–100) | 41 | 42 (highest) | 41 | 41 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 55 | 50 | 32 | 65 (highest) |
| Pricing power | 95 (highest) | 45 | 85 | 33 |
| Returns on capital | 4 | — | 11 (highest) | 4 |
| Balance-sheet safety | 28 | 28 | 55 (highest) | 40 |
| Capital allocation | 25 | 44 | 24 | 65 (highest) |
| 24% above value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $1.1B | $14651 | $167M | $2.0B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |